5:39 PM
 | 
May 22, 2013
 |  BC Extra  |  Company News

FDA to discuss Lotronex's REMS

FDA's Drug Safety and Risk Management Advisory Committee will meet on July 10 to discuss the Lotronex alosetron from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) and partner Prometheus Laboratories Inc., a unit of Nestle S.A. (SIX:NESN). Lotronex's ETASU require healthcare...

Read the full 187 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >